Psychiatric events induced by roflumilast: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System database - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Psychiatric Adverse Events Associated with Roflumilast: An Analysis of the FDA Adverse Event Reporting System Data

  • By

  • Lifang Wu

  • Yan Chen

  • Yaping Huang

  • Shaojun Jiang

  • Chengjie Ke

  • June 11, 2026

Share

Original Source(s)

Psychiatric events induced by roflumilast: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System database

  • by Lifang Wu, Yan Chen, Yaping Huang, Shaojun Jiang, Chengjie Ke

  • June 11, 2026

Related Content

Pharmacotherapy, acupoint stimulation, and psychotherapy for perimenopausal women with anxiety, depression, and panic disorder: a systematic review and network meta-analysis of randomized controlled trials

Taxonomy of access to mental healthcare for economically marginalized women during a public health crisis: a qualitative study of obstetric professionals and perinatal women during the COVID-19 pandemic

Natural Language Processing Applied to Psychiatric Clinical Notes: Scoping Review